Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates | Scientific Reports
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates
Emerging Trends in Single-Use Technology in the Manufacturing of ADCs
Development of Centrifugal Partition Chromatography for the Purification of Antibody–Drug Conjugates,Analytical Chemistry - X-MOL
Antibody Drug Conjugates (ADCs) Manufacturing | AbbVie CMO
Antibodies | Free Full-Text | A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation
Synthesis and Biological Evaluation of Antibody Drug Conjugates Based on an Antibody Expression System: Conamax | ACS Omega
Recombinant Human ADC protein (ABIN3089815)
Current approaches for the purification of antibody–drug conjugates - Matsuda - 2022 - Journal of Separation Science - Wiley Online Library
The development, purification, and production of antibody-drug conjugates | Download Scientific Diagram
Antibody Drug Conjugates – An Overview of the Technology and Manufacturing
Improving ADC Production and Purification | CHEManager
A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation. - Abstract - Europe PMC
Analyse & purification des protéines : HIC, la séparation des molécules selon leur hydrophobicité | Interchim - Blog France
Purification of ADCs by Hydrophobic Interaction Chromatography | SpringerLink
Antibodies | Free Full-Text | A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation
Antibodies | Free Full-Text | A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation
Antibody–Drug Conjugate Manufacturing Challenges - BioProcess InternationalBioProcess International
Trial of High Efficiency TFF Capsule Prototype for ADC Purification
Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer | PLOS ONE
